Koers AIT Therapeutics Inc OTC Bulletin Board
Aandelen
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 1,44 mln. 1,34 mln. | Omzet 2025 * | 13,2 mln. 12,3 mln. | Marktkapitalisatie | 51,87 mln. 48,35 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -62 mln. -57,8 mln. | Nettowinst (verlies) 2025 * | -64 mln. -59,66 mln. | EV/omzet 2024 * | 27,6 x |
Nettoliquiditeiten 2024 * | 12,15 mln. 11,33 mln. | Nettoschuld 2025 * | 2,95 mln. 2,75 mln. | EV/omzet 2025 * | 4,15 x |
K/w-verhouding 2024 * |
-0,58
x | K/w-verhouding 2025 * |
-0,65
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 82,02% |
Recentste transcriptie over AIT Therapeutics Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Lisi
CEO | Chief Executive Officer | 53 | 13-01-17 |
Douglas Larson
DFI | Director of Finance/CFO | 53 | 01-09-21 |
Amir Avniel
PSD | President | 50 | 13-01-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Bentsur
BRD | Director/Board Member | 58 | 01-08-15 |
William Forbes
BRD | Director/Board Member | 62 | 13-08-18 |
Erick Lucera
BRD | Director/Board Member | 57 | 10-08-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,77% | 184 mld. | |
-1,77% | 107 mld. | |
-1,43% | 67,52 mld. | |
+2,06% | 50,06 mld. | |
+9,43% | 45,67 mld. | |
+3,40% | 41 mld. | |
+3,04% | 26,73 mld. | |
+4,64% | 26,47 mld. | |
+15,23% | 25,05 mld. |